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Large genomic fragment deletion 
and functional gene cassette 
knock-in via Cas9 protein mediated 
genome editing in one-cell rodent 
embryos
Liren Wang1,2,*, Yanjiao Shao1,*, Yuting Guan1,*, Liang Li1, Lijuan Wu1, Fangrui Chen1, 
Meizhen Liu1, Huaqing Chen1, Yanlin Ma3, Xueyun Ma1, Mingyao Liu1,4 & Dali Li1
The CRISPR-Cas RNA-guided system has versatile uses in many organisms and allows modification 
of multiple target sites simultaneously. Generating novel genetically modified mouse and rat models 
is one valuable application of this system. Through the injection of Cas9 protein instead of mRNA 
into embryos, we observed fewer off-target effects of Cas9 and increased point mutation knock-in 
efficiency. Large genomic DNA fragment (up to 95 kb) deletion mice were generated for in vivo study 
of lncRNAs and gene clusters. Site-specific insertion of a 2.7 kb CreERT2 cassette into the mouse 
Nfatc1 locus allowed labeling and tracing of hair follicle stem cells. In addition, we combined the Cre-
Loxp system with a gene-trap strategy to insert a GFP reporter in the reverse orientation into the rat 
Lgr5 locus, which was later inverted by Cre-mediated recombination, yielding a conditional knockout/
reporter strategy suitable for mosaic mutation analysis.
Genetically engineered animals, especially the mouse and the rat, are of great value not only for basic 
research but more importantly for modeling diseases and developing therapeutic strategies1. The estab-
lishment of site-specific genomic engineering through autonomous homologous recombination in mouse 
embryonic stem cells represented a major scientific breakthrough2,3. Although conventional gene tar-
geting is costly, labor and time intensive, and inefficient1,4, it has been used for modification of large 
genomic DNA fragments5–7. Through generation of site-specific DNA double-strand breaks (DSBs), pro-
grammable nucleases (such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases 
(TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)-associated 9 (Cas9) 
systems) have been widely used in precise genomic editing to generate knockout, knock-in and chro-
mosomal rearrangements in cells and animals8–11. Distinct from ZFNs and TALENs which recognize the 
target genomic loci via a pair of tandem repeats, the modified CRISPR/Cas system recognizes the target 
site through a core endonuclease, Cas9, and a synthetic single guide RNA (sgRNA) that directs Cas9 to 
its target DNA through Watson-Crick base-paring rules. The only requirement of the DNA target is the 
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existence of a PAM (protospacer-adjacent motif) sequence (-NGG for Cas9 from S. pyogenes) directly 
downstream of the seed region of the target site12,13. Due to its flexibility, convenience and high efficiency, 
many potential applications of CRISPR/Cas system have been explored in depth14. However, the prob-
lem of off-target effects of Cas9 mediated gene targeting is still a great concern for researchers although 
a series of studies have demonstrated improved specificity through double-nicking or shortening the 
sgRNA length15,16.
The high frequency off-target effects in cells with the CRISPR/Cas system is hypothesized to be par-
tially due to prolonged nuclease activity in stable cell lines17. Recently, two groups reported that through 
introduction of recombinant Cas9 protein and sgRNAs into cells, both the activity and the accuracy of 
the CRISPR/Cas system has been improved17,18. Although initial work suggested highly efficient genera-
tion of gene knockout zebrafish and mice through direct injection of Cas9 protein/sgRNA19,20, only a few 
reports described the successful knockout of a large DNA fragment21 or knock-in of a functional gene 
cassette using this method22–24. Here, we investigated the generation of multiple animal models using 
Cas9 recombinant protein for large genomic DNA deletion and functional gene cassette knock-in. In 
addition, we found that injection of Cas9 protein rather than Cas9 mRNA slightly increased the knock-in 
efficiency and lowered the incidence of off-target effects. Our study suggests that recombinant Cas9 
protein is an excellent alternative choice for generation of various genetically modified animal models.
Results
Deletion of a large genomic fragment in mice by injection of Cas9 protein and sgRNA 
pairs. Previously, we and others successfully generated mutant mouse and rat models through injec-
tion of either DNA or RNA encoding corresponding Cas9/sgRNA24–27. As delivery of Cas9 protein is an 
alternative method with potential advantages that has not been fully tested in model organisms19, here 
we sought to extensively expand the applications for generation of genetically modified animals through 
injection of Cas9 protein. The recombinant Cas9 protein was purified and its activity was confirmed in 
an in vitro cleavage test using commercial Cas9 enzyme as a positive control. (Data not shown).
Creating small indels usually could not disrupt long non-coding RNA (lncRNA) genes due to the 
lack of an open reading frame28. Although previous reports have shown a maximum deletion of 10 kb 
of genomic DNA via direct injection of two sgRNAs into one cell mouse embryos21,29, a further attempt 
to delete a 30 kb genomic region was unsuccessful21. Moreover, the performance of Cas9 protein injec-
tion to generate large genomic deletions has not been reported. To test the efficiency of Cas9 protein 
mediated large DNA fragment deletion we injected Cas9 protein into one-cell mouse embryos together 
with two sgRNAs targeting exon1 and 2 of lncRNA GM14005 genomic DNA, a region spanning 53 kb 
(Supplementary Fig. S1a). Among 5 F0 pups, 1 founder was confirmed by PCR genotyping with subse-
quent sequencing (Supplementary Fig. S1b and Table 1). The 53 kb deletion was efficiently transmitted 
to the F1 generation (Supplementary Fig. S1b).
As some homologous genes are located adjacent to one another to form a gene cluster, it is difficult 
to generate multiple-gene knockout animals by crossing due to the low homologous recombination effi-
ciency within short distances in the genome. Therefore, we next tried to delete a genomic region which 
spans 95 kb in the mouse genome containing three receptors for formyl peptide to extend the deletion 
range through direct embryo injection (Fig.  1a). After injection of Cas9 protein:sgRNAs, 20 F0 pups 
were obtained. PCR and subsequent DNA sequencing confirmed that two pups were founders bearing 
the desired 95 kb genomic DNA deletion (Fig. 1b, Table 1). The deletion was germline transmissible as 
determined by genotyping of F1 progeny (Fig. 1c). We demonstrated that through a single injection of 
Cas9 proteins and two sgRNAs, large DNA fragment deleted animals could be easily generated.
Off-target effect studies of Cas9 protein-mediated genome editing in mouse embryos. It 
was reported that reducing the amount of Cas9/sgRNA plasmid DNA during transfection increased the 
Gene
Injected 
embryos
Transferred 
embryos (%)
Live 
Newborns (%) Indels/deletions (%)
HDR 
(%)
Sin1 154 83(54) 11(13) 9(82) 1(11)
Sirt3(mRNA) 204 120(59) 21(17) 12(57) 2(17)
Sirt3(protein) 144 90(62) 9(10) 7(78) 2(28)
Gm14005 61 51(84) 5(10) 1(20) N/A
Fpr1-3 115 82(71) 20(24) 2(10) N/A
Nfatc1 97 66(68) 16(24) 4(25) 1(6)
Lgr5 123 89(72) 3(3) N/A 2(66)
Table 1.  Cas9 protein:sgRNA mediated gene modification in mice and rats. Percentages were calculated 
using the number in each column as the numerator and the number in the column to its left as the 
denominator.
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cleavage specificity30. As Cas9 protein exhibits a shorter duration than DNA/RNA transfected into the 
cell, we assumed that injection of Cas9 protein could be helpful to increase the targeting specificity. To 
check for potential off target activities by Cas9 protein, we chose a previously reported sgRNA that targets 
the mouse androgen receptor (Ar) locus31. After injection of Cas9 protein:sgRNA, 3 on-target mutant 
F0 pups were identified by T7E1 digestion (Fig.  2a). The efficiency was comparable with a previous 
report31. Two potential off-target sites were analyzed by T7E1 assay followed by sequencing (Fig. 2b,c). 
For each off-target site, 1 of 3 founders exhibited off-target digestion (Fig. 2b,c). It was reported that all 
3 on-target founders contained both of these two off-target mutations in mice generated via injection of 
Cas9 mRNA31. The off-target frequency was reduced when we injected Cas9 protein, but the on target 
efficiency was consistent with previous reports17. This is probably due to the shorter half-life of Cas9 
protein compared to Cas9 mRNA and its subsequent translation17,32. The results suggested that Cas9 
protein injection could be used as an alternative way to generate mutations with the potential benefit of 
reducing off-target digestion.
Figure 1. Deletion of the Fpr1-3 gene cluster by two sgRNAs spanning 95 kb. (a) Schematic overview 
of the strategy to delete a 95 kb DNA fragment on chromosome 17. The exons Fpr1 and Fpr3 are labeled 
in blue and purple respectively, and the target sites are indicated by arrowheads. PAM sequences are in 
red following the target sequence highlighted in blue or purple. After deletion of the DNA fragment, the 
resulting genomic sequence is composed of the 5′ part of Fpr1 (blue) and the 3′ portion of Fpr3 (purple). 
The locations of PCR primers (F, Forward; R, reverse) are indicated by arrows. (b) (Top) Genotyping of 
the founders. PCR analysis of F0 mice injected with Cas9 protein and sgRNAs listed in (a). Arrowheads 
indicate the founders with deletion of the 95 kb genomic DNA fragment. (Below) Sequencing data of 
the PCR products from two founders showing the joint Fpr1/Fpr3 genomic sequence. M, DNA marker. 
(c) Genotyping analysis of F1 progenies from two founders showing germ line transmission of the 95 kb 
deletion. M, DNA marker.
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Comparing the HDR efficiency mediated by Cas9 protein and Cas9 mRNA. Nuclease-induced 
DNA double-strand breakage stimulates HDR efficiency. To test the efficiency of Cas9 protein-mediated 
point mutations, we tried to generate an Arg84Thr (ga > cg) mutation in the mouse Sin1 genomic locus 
(Supplementary Fig. S2a). As the mutation site is outside the sgRNA seed region, we designed the donor 
template by introducing 6 synonymous mutations within the sgRNA target sequence to avoid re-digestion 
of the target after HDR. In addition, to test whether a mutation outside the targeting sequence can be 
introduced into the genome, we also designed a substitution 35bp away from the PAM to introduce a 
restriction enzyme (PvuII) recognition site (Supplementary Fig. S2a). After pronuclear injection, 11 F0 
pups were obtained and 9 of them contained a modified Sin1 locus (Supplementary Fig. S2b, Table 1). 
Although 3 pups (#5, #8 and #11) received the 6 synonymous mutations, the desired Arg84Thr (ga > cg) 
mutation was only identified in 1 pup (#8). In F0 pup #5, a 61 bp random sequence was inserted 5′ to the 
target sequence. In F0 pup #11, the mutant sequence was inserted near the PAM. Although nucleotide 
substitutions occurred in 7 of 9 F0 pups, none of them carried the g > c mutation 35 bp away from PAM, 
suggesting that mutation far away from the PAM is difficult to introduce.
Our above results suggest that delivery of Cas9 protein:sgRNA:ssODN is capable of introducing muta-
tions through an HDR mechanism. Since HDR is cell cycle dependent and Cas9 protein should function 
faster than Cas9 mRNA once injected into the pronucleus, we assumed that the HDR efficiency following 
Cas9 protein injection was different from that of Cas9 mRNA injection. To compare the HDR efficiency 
between injection of Cas9 protein and Cas9 mRNA, we designed an sgRNA targeting the mouse Sirt3 
locus and synthesized the corresponding ssODN template which contains 4 substitutions in the target 
sequence and 1 substitution near the PAM on the opposite side (Fig.  3a). Of 21 newborn pups in the 
Cas9 mRNA group, 12 pups carried indels. Only 2 of them were founders bearing the desired knock-in 
mutation. In the Cas9 protein injection group 7 of 9 pups carried indels with 2 of them bearing the 
desired knock-in mutation. These results suggested that injection of Cas9 protein could give a slightly 
higher indel (7/9 = 78% vs 12/21 = 63%) and increased HDR (2/9 = 22% vs 2/21 = 9.5%) rate than Cas9 
mRNA injection (Fig.  3b and Table  1); however more experiments should be carried out to confirm 
Figure 2. Off-target analysis of sgRNA targeting the AR genomic locus. (a) Genomic DNA extracted 
from 12 F0 pups was subjected to PCR with on-target primers and subsequent T7E1 digestion. On-target 
mutants are indicated by arrowheads. M, DNA marker. (b) T7E1 digestion analysis of founders on two 
off-target (OT) sites. The sequence of On-target and OT sites are listed. The PAM sequences are in red and 
mismatched nucleotides are in blue. (c) The sequences of the OT sites of the founders bearing mutations are 
listed.
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this phenomenon on different genomic loci. In addition, the group that received Cas9 mRNA injection 
exhibited higher chimerism in some pups compared to the Cas9 protein injection group (Fig. 3b).
Generation of Nfatc1-IRES-CreERT2 knock-in mice for lineage tracing. Site-specific insertion 
of functional cassettes containing relatively long DNA fragments into the mouse or rat genome through 
customized nucleases is challenging. As the CreERT2 cassette is widely used for inducible knockout 
and lineage tracing studies, we next tried to insert a 2.7 kb IRES-CreERT2 cassette into the mouse 
Nfatc1 locus (Fig. 4a). We constructed a donor template with about 600 bp homology arms flanking the 
IRES-CreERT2 cassette. Among 16 F0 pups 4 carried indels as shown by T7E1 assay (Fig. 4b upper) and 
1 founder was identified with two sets of genotyping primers (Fig. 4b, Table 1). The insertion was also 
confirmed by sequencing the PCR products (data not shown). We observed highly efficient germline 
transmission in the F1 generation (Fig. 4b). To test if the inserted CreERT2 cassette functions in vivo, the 
Nfatc1-CreERT2 strain was crossed with the Rosa26-LSL-LacZ reporter strain. As Nfatc1 is expressed in 
CD34+ hair follicle stem cells33, we initiated cell lineage tracing by intraperitoneal injection of tamoxifen 
at the age of 4 weeks when the hair cycle is in the transition from first telogen to second anagen. 2 days 
after induction, LacZ positive cells were detected in the bulge area of the hair follicles (Fig.  4c mid), 
suggesting that Nfatc1 marks the bulge cells during anagen as reported33. 4 weeks after induction when 
the hair follicles were in the second telogen stage, LacZ positive cells occupied the entire hair follicle 
Figure 3. Comparison of the knock-in efficiency between injection of Cas9 protein and Cas9 mRNA. 
(a) Schematic overview of the strategy to introduce specific mutations in the Sirt3 locus. PAM sequence is 
labeled in red, designed mutations are blue. (b) The sequence of F0 pups generated from Cas9 mRNA (left) 
or protein (right) injection are listed. Founders with the desired mutation are labeled with a red asterisk. 
PAM sequence is red, designed mutations are blue, random mutations are green.
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(Fig. 4c right), suggesting that Nfatc1-positive cells are follicle stem cells in the bulge. When induced at 
the 8th week for 2 days, only stem cells in the bulge area exhibited β -Gal staining (data not shown). To 
our knowledge, this is the first evidence to show that Nfatc1 marks the hair follicle stem cells through 
lineage-tracing studies.
Cas9 protein mediated direct insertion of a DNA cassette into the Lgr5 locus to generate a 
conditional knockout rat allele with a reporter. Mosaic mutant analysis is a powerful strategy to 
study individual mutant cells in a wild-type cellular environment. The challenge of this technique is to 
label the truly knockout cells while avoiding mis-labeling wild-type cells when the reporter activation 
is independent of conditional knockout of the target gene34. We attempted to generate a conditional 
knockout rat strain whose cells can be labeled after disruption of the target gene by Cre recombinase. We 
took advantage of the gene trap strategy together with Cre-Loxp-mediated DNA inversion35 to inactivate 
Figure 4. Site-specific insertion of IRES-CreERT2-pA into the mouse Nfatc1 locus. (a) Schematic of the 
strategy for insertion of the CreERT2 cassette into the mouse Nfatc1 locus. Cas9/sgRNA targeted the 3′ UTR 
of the Nfatc1 gene in Exon 9. The HDR donor sequence consists of IRES-CreERT2-polyA (2.7 kb) flanked by 
two homologous arms 650 bp (left-arm) and 600 bp (right-arm) in length. Positions of genotyping primers 
are indicated by arrows. (b) Genotyping of Nfatc1-CreERT2 mice. Upper, T7E1 assay to check the indels 
created by CRISPR/Cas. Middle, identification of founder (F0) and F1 Nfatc1-CreERT2 mice by primer 
pairs: F1 + R1 and F2 + R2. Arrowheads: desired bands of site-specific inserted pups. M, DNA marker.  
(c) Lineage tracing of skin Nfatc1 stem cells in Nfatc1-CreERT2+/−:Rosa26-LacZ+/− mouse via X-gal 
staining. Lineage tracing began at the age of 4 weeks by intraperitoneal injection of tamoxifen. Mice dorsal 
skin tissue was stained 2 days (middle) or 4 weeks (right) after induction. Scale bar, 100 μ m.
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the target gene while simultaneously labeling cells with GFP (Fig.  5a,b). Lgr5 is a biomarker of adult 
stem cells in certain tissues, including the intestine, stomach, hair follicle36. However, the study of adult 
stem cells is hampered in rats due to the lack of reporter strains. We intended to generate an Lgr5 con-
ditional knockout/reporter line by using the above strategy to facilitate monitoring adult stem cells in 
their native context. Using the Cas9 protein/sgRNA system, we inserted a DNA cassette (composed of a 
splice acceptor (SA) sequence, the green fluorescent protein (GFP) coding sequence and a polyadenyla-
tion (PA) sequence flanked by two pairs of lox66 and lox71 sites) in the reverse orientation into intron 
1 of the rat Lgr5 locus (Fig. 5a left). After PCR and subsequent sequencing, 2 founders were confirmed 
from 3 F0 pups (Fig. 5a right, Table 1). Interestingly, founder #3 was highly likely to carry homozygous 
Figure 5. Site-specific insertion of reverse oriented SA-GFP-pA into the rat Lgr5 locus. (a) Left, 
schematic of the strategy to insert the inverted GFP reporter cassette into intron1 of the rat lgr5 locus. The 
reporter cassette consists of a splice acceptor (SA), GFP and polyA (pA) sequences flanked by heterospecific 
Loxp twin-sites in opposite orientations and homologous arms each about 800 bp long. Right, Genotyping of 
the founder and the F1 heterozygous mice. Arrowheads indicate the detection of the GFP reporter cassette 
insertion into the Lgr5 locus in F0 or F1 rats. Asterisk, the PCR band amplified from the wild-type allele. 
Arrows represent the positions of genotyping primers. M, DNA Marker. (b) Left, schematic depiction of 
Cre mediated cassette inversion, Loxp site excision and lgr5 inactivation. The reporter cassette was first 
inverted by Cre recombinase between either inverted Loxp pairs. Thereafter, Cre mediated excision deletes 
the sequence in between the identically-oriented Loxp pairs, leaving one WT and one mutant Loxp site. 
Right, RT-PCR to detect endogenous Lgr5 mRNA by primer pair RT1&RT3 and Lgr5-GFP fusion mRNA 
by primer pair RT1&RT2. Arrows represent the positions of RT-PCR primers. Lower, sequencing result 
indicating the fusion of Lgr5 and SA-GFP-pA. M, DNA Marker. (c) Detection of GFP (red arrowhead) in rat 
small intestine tissue after Cre-mediated recombination through immunohistochemical staining. Scale bar, 
100 μ m.
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mutation identified from tail DNA. However, after crossing with a wild-type rat, only half of the F1 
generation from founder #3 was heterozygous suggesting that the founder was a mosaic in germ cells 
(Fig. 5a right). In principle, upon Cre-mediated recombination, the reverse-oriented SA-GFP-pA cassette 
will be inverted, then produce a truncated Lgr5 protein fused with GFP. Thus the GFP fusion proteins 
will label the cells having a spontaneous disruption of the endogenous Lgr5 gene (Fig. 5b left). To test 
whether the cassette is functional in vivo, we injected Cre mRNA into heterozygous one-cell embryos 
due to the unavailability of the appropriate rat Cre line. As shown in Fig. 5b, the reporter cassette was 
inverted in the genome, and the Lgr5-GFP fusion mRNA was detected in the rat intestine and confirmed 
by sequencing. Furthermore, the GFP+ cells were detected in the bottom of the intestinal crypts where 
Lgr5+ stem cells reside (Fig.  5c and Supplementary Fig. S3). To our knowledge, this is the first report 
of marking stem cells in the rat intestine. Intercrossing F1 heterozygotes of Lgr5gfp/+ rats yielded 35 F2 
progenies including 13 wild types and 22 heterozygotes (WT: HZ≈ 1:1.7 ). The lack of homozygous rats 
in the F2 progenies indicates prenatal lethality of Lgr5 knockout in rats which is a more severe phenotype 
than that observed in Lgr5 knockout mice which exhibited neonatal lethality37.
Discussion
The CRISPR/Cas system is a powerful tool for genetic modification in cells and animals. Although mul-
tiple applications such as generation of indels, deletions, Loxp-inserted conditional alleles, and insertion 
of GFP reporters have been reported through genomic engineering in mammalian model organisms24,27, 
the execution of complicated genomic editing via Cas9 in embryos has not been extensively studied. 
In this report, through injection of Cas9 protein, we generated mouse strains with large genomic DNA 
deletions as well as mouse or rat strains with site-specific insertion of Cre or reporter cassettes. Our study 
extensively confirmed that injection of recombinant Cas9 protein is an alternative strategy to generate a 
variety of genetically modified mammalian models.
Through large DNA fragment deletion by Cas9/sgRNA, it is practicable to generate mouse strains 
to model human genetic disorders which are caused by the loss of large DNA fragments. Although a 
recent publication reported the generation of mice with a 1.6 Mb deletion in their genome, technically 
the authors used ESC aggregation to generate the mouse after screening for the right ESC clone38. This 
procedure takes at least 10 weeks to get the F0 chimera whose germline transmission efficiency varies 
case by case. Generation of genetically modified animals with Cas9 through an ESC-based strategy is 
still an expensive, time consuming and laborious strategy. Recent publications have shown generation 
of a 10 kb deletion of mouse genomic DNA by direct injection of Cas9 mRNA/sgRNA21,29. Our current 
work expanded the upper limit of large-scale genomic DNA deletion by creating F0 founder mice with 
LncRNA GM14005 genomic DNA (53 kb) deletion or formyl peptide receptor paralog (Fpr1-3) gene 
cluster (95 kb) deletion at high efficiency within 4 weeks. To our knowledge, this is the largest DNA frag-
ment deletion in mammalian models generated through gene editing technology in embryos suggesting 
the potential of CRISPR/Cas in the study of polygenic diseases caused by contiguous genes.
Double-nicking Cas9 and dCas9-FokI strategies were effective in greatly reducing the incidence of 
off-target digestion31,39. However, these two strategies decrease the on-target activity of Cas9 nuclease. 
It was reported that introduction of Cas9 protein:sgRNA into cells decreased off-target effects but not 
on-target digestion17,19. Our results also suggested that it is feasible to reduce off-target efficiency through 
injection of Cas9 protein in embryos. This is likely because the Cas9 protein has a relatively shorter 
half-life in embryos than Cas9 mRNA, yielding fewer off-target hits. Site-specific knock-in or substi-
tution is valuable for gene editing; however the efficiency is pretty low due to inefficient homologous 
recombination. Three targets were injected both through mRNA and protein in parallel experiments and 
the frequency of chimerism was decreased in the protein injected groups (Fig. 3 and data not shown). In 
our experience, the HDR efficiency varies from one genomic locus to another. In some cases, the sgRNA 
efficiency to induce NHEJ mutations is high (above 60%), but yields no knock-ins after several rounds of 
injection (data not shown). It is not clear whether it depends on the chromatin status or not. We used the 
Sirt3 locus to compare the knock-in efficiency of Cas9 mRNA injection and protein injection. Our data 
suggested that the HDR rate is slightly increased in the protein injected group (Fig. 3b), which is con-
sistent with the results of cell cycle dependent introduction of Cas9 protein into cell lines32. More exper-
iments need to be done to further confirm that the HDR efficiency is increased through Cas9 protein 
injection. A recent study is consistent with our results that injection of Cas9 protein in mouse embryos 
led to higher HDR efficiency, although the authors used dual-crRNA:tracrRNA instead of sgRNA22.
Knock-in of large DNA fragments into embryos is challenging for gene editing technology due to low 
efficiency. We showed that a functional 2.7 kb CreERT2 cassette was successfully inserted into the mouse 
Nfatc1 locus. As the coding sequence of more than 85% of human protein-coding genes is under 3 kb40, 
in principle the CRISPR/Cas system can be used to introduce most human genes for the generation of 
humanized models. We also developed a strategy for mosaic mutant analysis which can be used to label 
the cells once the target gene is inactivated by Cre recombinase (Fig.  4d,e). In our Lgr5 conditional 
knockout/reporter stain, the GFP fluorescence could not be directly detected through microscopy. It is 
possible that the Lgr5 promoter is not strongly expressed in the rat intestine. It is also possible that the 
N-terminus of Lgr5 fused to GFP after cassette inversion disrupted the structure necessary for GFP flu-
orescence. Our results suggest it is better to avoid the production of fusion proteins by insertion of IRES 
or T2A sequences between the SA and the GFP sequence. Although the strategy worked well in this case, 
www.nature.com/scientificreports/
9Scientific RepoRts | 5:17517 | DOI: 10.1038/srep17517
there are two concerns remaining. First, it is not clear if the inverted insertion of the L-SA-GFP-PA-L 
cassette in the intron affects the endogenous gene. Second, after Cre-mediated recombination, the cas-
sette may not completely inactivate the endogenous gene as sometimes the artificial exon is neglected as 
reported in some cases of gene-trapped mouse models. We also noticed a lower efficiency in the Nfatc1 
locus knock-in experiment than in the Lgr5 locus. This is probably due to the longer knock-in cassette 
(Nfatc1: 2.7 Kb vs Lgr5: 1.1 Kb) and lower sgRNA activity (Nfatc1, 25% vs Lgr5, 66%). Although other 
group suggested that higher HDR efficiency was achieved in some genomic loci in rat embryos41,42, it is 
difficult to evaluate the HDR efficiency in Lgr5 locus due to limited pups obtained in this study.
In summary, this report suggests that the performance of Cas9 protein is comparable or even better 
than Cas9 mRNA for generation of genetically modified animal models, although more experiments 
should be done to confirm this. Our results exhibit the great potential of Cas9 in creating genetically 
modified mice and rats, paving its way for future applications in disease modeling for basic scientific 
research and in humanized models for gene therapies.
Materials and Methods
Recombinant Cas9 expression and purification. The Cas9 open reading frame was amplified from 
pX33043 (Addgene #42230) and cloned into pET28a in frame with an N-terminal His-6 tag for in vitro 
expression. Cas9 protein was expressed in Transetta (DE3) (Transgen Biotech), induced at OD 0.8 with 
0.2 mM IPTG followed by at least 16 hours of expression at 18 °C. The protein was bound to Ni-NTA 
Agarose (Qiagen) and washed extensively with 20 mM Tris PH 8.0, 500 mM NaCl, 10% glycerol, followed 
by linear gradient elution with 500 mM imidazole, 20 mM Tris PH 8.0, 250 mM NaCl, 10% glycerol. 
Fractions over 90% purity were dialyzed against 150 mM KCl, 20 mM Tris PH 7.5, 1 mM DTT, 10% 
glycerol, aliquoted, and stored at − 80 °C.
In vitro sgRNA and Cas9 mRNA synthesis. DNA templates of Cas9 and sgRNAs were first amplified 
by PCR using 5′ primers containing SP6 and T7 promoters respectively as previously described21. In vitro 
transcription of Cas9 mRNA was performed using the mMESSAGE mMACHINE kit (Ambion). sgRNAs 
were transcribed in vitro by T7 transcription kit (Takara) according to the manufacturer’s instructions. 
All single stranded oligonucleotide DNA donors were ordered from Biosune Inc.
Microinjection of zygotes. All animal experiments were performed in accordance with the regula-
tions of the Association for Assessment and Accreditation of Laboratory Animal Care in Shanghai and 
were approved by the East China Normal University Center for Animal Research (AR2013/04009).
Microinjection was performed as described previously22. C57BL/6J mice and Sprague Dawley (SD) rats 
were purchased from SLAC Shanghai. In brief, mouse and rat one-cell embryos were obtained by super-
ovulation of females mated with males with the same genetic background. The embryos were harvested 
in M2 medium and cultured in KSOM medium (Millipore) for 2–3 hours. In the knock-in experiments, 
TE solution containing 12.5 ng/ul sgRNA, 10–50 ng/ul DNA donor, 30 nM Cas9 protein (or 25 ng/μ l Cas9 
mRNA in the Sirt3 point mutation experiment) was injected into the pronuclei of one-cell stage embryos. 
In the Ar knockout experiment 30 nM Cas9 protein was injected into the cytoplasm of the one-cell stage 
embryos with the corresponding sgRNA. Injected embryos were transferred into pseudopregnant female 
mice or rats immediately after injection or the next morning after overnight culture in KSOM.
Genotyping and sequence analysis. Genomic DNA from tails of the progenies was extracted and 
subjected to PCR using the indicated primers followed by DNA sequencing analysis. To check for point 
mutations and off-target effects, the genomic region encompassing the targeted region was PCR ampli-
fied, purified and reannealed followed by digestion with T7 endonuclease I (NEB or Beijing Polymath) 
and then analyzed by agarose gel electrophoresis. The exact sequences were determined by Sanger 
sequencing. Sequences of all primers are listed in Table S1.
β-Galactosidase Staining. Nfatc1-CreERT2:Rosa26-LSL-lacZ mice were injected intraperitoneally 
with 100 μ l tamoxifen (20 mg/ml) at the age of 4 weeks. Mice were euthanized 2 days or 4 weeks after 
tracing and mouse dorsal skin tissue from the mid back was collected, washed with ice-cold LacZ fixing 
buffer (2% formaldehyde, 0.2% glutaraldehyde, 0.02% Nonidet P-40), followed by incubation in fixing 
buffer for 2 h on a shaker at 4 °C. Then the skin tissues were washed with LacZ wash buffer (2 mM MgCl2, 
0.01% deoxycholate, 0.02% Nonidet P-40 in PBS, PH 8.0) twice (10 min each time), followed by incubat-
ing overnight in staining buffer (0.5 mg/ml X-gal dissolved in LacZ wash buffer) at room temperature. 
Tissues were then fixed, embedded in paraffin and sectioned for histological analysis.
Immunohistochemistry and immunofluorescence staining. Mice or rats were sacrificed by car-
bon dioxide asphyxiation. For immunohistochemistry, tissues were fixed with 4% paraformaldehyde 
(PFA), embedded in paraffin, sectioned at 4 μ m followed by de-waxing and rehydration. Sections were 
incubated with 3% H2O2 in methanol for 20 min, washed in PBS, followed by antigen retrieval in 10 mM 
sodium citrate, PH 6.0 at 100 °C. After blocking in 1% BSA for 30 min at room temperature, rat liver 
sections were incubated with 1:500 diluted anti-Fah (purified from immunized rabbit serum) antibody 
and small intestine sections were incubated with 1:500 diluted anti-GFP antibody (Santa Cruz SC-9996) 
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overnight. Sections were developed with diaminobenzidine and counterstained with hematoxylin fol-
lowing a 30 min incubation with secondary antibody. For immunofluorescence, rat small intestines were 
embedded in OCT, frozen, cryo-sectioned and fixed in 4% PFA. Thereafter sections were stained with 
anti GFP antibody and subjected to immunofluorescence microscopy.
References
1. Gaj, T., Gersbach, C. A. & Barbas, C. F. III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in 
Biotechnology 31, 397–405 (2013).
2. Doetschman, T. et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576–578 (1987).
3. Thomas, K. R. & Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 
503–512 (1987).
4. Capecchi, M. R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. 
Genet. 6, 507–512 (2005).
5. Rongvaux, A. et al. Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol 32, 
364–372 (2014).
6. Lee, E.-C. et al. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat 
Biotechnol 32, 356–363 (2014).
7. Ramírez-Solis, R., Liu, P. & Bradley, A. Chromosome engineering in mice. Nature 378, 720–724 (1995).
8. Carbery, I. D. et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics 186, 451–459 (2010).
9. Sung, Y. H. et al. Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31, 23–24 (2013).
10. Geurts, A. M. et al. Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases. Science 325, 433–433 (2009).
11. Qiu, Z. et al. High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases. Nucleic Acids 
Research 41, e120–e120 (2013).
12. Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided 
endonuclease Cas9. Nature 507, 62–67 (2014).
13. Nishimasu, H. et al. Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA. Cell 156, 935–949 (2014).
14. Hsu, P. D., Lander, E. S. & Zhang, F. Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell 157, 
1262–1278 (2014).
15. Ran, F. A. et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell 154, 1380–1389 
(2013).
16. Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide 
RNAs. Nat Biotechnol 32, 279–284 (2014).
17. Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of 
purified Cas9 ribonucleoproteins. Genome Res. 24, 1012–1019 (2014).
18. Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. 
Nat Biotechnol 1–10 (2014), doi: 10.1038/nbt.3081.
19. Sung, Y. H. et al. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res. 24, 
125–131 (2014).
20. Gagnon, J. A. et al. Efficient Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion and Large-Scale Assessment of 
Single-Guide RNAs. PLoS ONE 9, e98186–8 (2014).
21. Brandl, C. et al. Creation of targeted genomic deletions using TALEN or CRISPR/Cas nuclease pairs in one-cell mouse embryos. 
FEBS OPEN BIO 5, 26–35 (2015).
22. Aida, T. et al. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol. 16, 87 (2015).
23. Ma, Y. et al. Generating rats with conditional alleles using CRISPR/Cas9. Cell Res 24, 122–125 (2014).
24. Yang, H. et al. One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome 
Engineering. Cell 154, 1370–1379 (2013).
25. Li, D. et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31, 681–683 (2013).
26. Shao, Y. et al. CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos. Nat Protoc 9, 2493–2512 
(2014).
27. Wang, H. et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome 
Engineering. Cell 153, 910–918 (2013).
28. Ho, T. T. et al. Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Research 43, e17–e17 
(2015).
29. Fujii, W., Kawasaki, K., Sugiura, K. & Naito, K. Efficient generation of large-scale genome-modified mice using gRNA and CAS9 
endonuclease. Nucleic Acids Research 41, e187–e187 (2013).
30. Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827–832 (2013).
31. Shen, B. et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Meth 11, 399–402 
(2014).
32. Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing 
of CRISPR/Cas9 delivery. Elife 3, e04766 (2014).
33. Horsley, V., Aliprantis, A. O., Polak, L., Glimcher, L. H. & Fuchs, E. NFATc1 Balances Quiescence and Proliferation of Skin Stem 
Cells. Cell 132, 299–310 (2008).
34. Joyner, Z. L. G. N. R. C. N. B. A., Raju, G. P., Bai, C. B. & Joyner, A. L. MASTR: A Technique for Mosaic Mutant Analysis with 
Spatial and Temporal Control of Recombination Using Conditional Floxed Alleles in Mice. CellReports 2, 386–396 (2012).
35. Schnütgen, F. et al. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat 
Biotechnol 21, 562–565 (2003).
36. Muñoz, J. et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+ 4’ cell markers. The EMBO 
Journal 31, 3079–3091 (2012).
37. Morita, H. et al. Neonatal Lethality of LGR5 Null Mice Is Associated with Ankyloglossia and Gastrointestinal Distension. 
Molecular and Cellular Biology 24, 9736–9743 (2004).
38. Kraft, K. et al. Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice. CellReports 10, 
833–839 (2015).
39. Guilinger, J. P., Thompson, D. B. & Liu, D. R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of 
genome modification. Nat Biotechnol 32, 577–582 (2014).
40. Ota, T. et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36, 40–45 (2004).
41. Ma, Y. et al. Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS J. 281, 3779–3790 (2014).
42. Ma, Y. et al. Generating rats with conditional alleles using CRISPR/Cas9. Cell Res 24, 122–125 (2013).
43. Cong, L. et al. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science 339, 819–823 (2013).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:17517 | DOI: 10.1038/srep17517
Acknowledgements
We thank Dr. Stefan Siwko for scientific editing and comments. This work was partially supported by 
grants from the State Key Development Programs of China (2012CB910400 to ML, 2012CB966502 to 
YM), grants from the National Natural Science Foundation of China (no. 31371455, 31171318, 81330049, 
81060016, and 31140021), and a grant from the Science and Technology Commission of Shanghai 
Municipality (14140900300).
Author Contributions
L.W., Y.G., Y.S., L.L. and L.W. did the experiments and analyzed the data, M.L., H.C. and F.C. did the 
microinjection, Y.M. and X.M. analyzed the data, M.L. designed the experiments, and D.L. designed the 
experiments, analyzed the data and wrote the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Wang, L. et al. Large genomic fragment deletion and functional gene cassette 
knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci. Rep. 5, 17517; 
doi: 10.1038/srep17517 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
